Safety signals of perfluorohexyloctane ophthalmic solution in patients with dry eye disease - Scorecard - MDSpire

Safety signals of perfluorohexyloctane ophthalmic solution in patients with dry eye disease

  • By

  • Zhengtai Sun

  • Yuting Liu

  • Lijuan Que

  • May 28, 2026

Share

Clinical Scorecard: Evaluation of Safety Indicators for Perfluorohexyloctane Ophthalmic Solution in Individuals with Dry Eye Disease

At a Glance

CategoryDetail
Condition
Key MechanismsRemove unsupported claims and ensure it is directly sourced.
Target Population
Care Setting

Key Highlights

  • remove

Guideline-Based Recommendations

Diagnosis

    Management

    • R
    • e
    • m
    • o
    • v
    • e
    • u
    • n
    • s
    • u
    • p
    • p
    • o
    • r
    • t
    • e
    • d
    • r
    • e
    • c
    • o
    • m
    • m
    • e
    • n
    • d
    • a
    • t
    • i
    • o
    • n
    • s
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Adults aged 18 and older with Dry Eye Disease.

        Perfluorohexyloctane ophthalmic solution is a novel, preservative-free formulation with demonstrated short-term efficacy.

        Clinical Best Practices

        • remove

        Related Resources & Content

        Original Source(s)

        Safety signals of perfluorohexyloctane ophthalmic solution in patients with dry eye disease

        • by Zhengtai Sun, Yuting Liu, Lijuan Que

        • May 28, 2026

        Related Content

        Mapping Clinical Evidence from Randomized Controlled Trials on Acupuncture and Moxibustion for the Management of Dry Eye Disease

        When Vision Fluctuates, Look to the Tear Film First

        Dr. Theriot discusses the differences between natural tear film and artificial tears—and why the change in moniker to "lubricating drops" is appropriate.

        Association of a novel meibomian gland dysfunction composite score with corneal nerve parameters and ocular surface symptoms in dry eye disease